NORTH
CHICAGO, Ill., Feb. 16,
2023 /PRNewswire/ -- The board of directors of AbbVie
Inc. (NYSE: ABBV) today declared a quarterly cash dividend of
$1.48 per share.
The cash dividend is payable May 15,
2023, to stockholders of record at the close of business on
April 14, 2023.
Since the company's inception in 2013, AbbVie has increased its
dividend by more than 270 percent. AbbVie is a member of the
S&P Dividend Aristocrats Index, which tracks companies that
have annually increased their dividend for at least 25 consecutive
years.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. We strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology, and gastroenterology,
in addition to products and services across our Allergan Aesthetics
portfolio. Follow @abbvie on Twitter, Facebook, Instagram, YouTube
and LinkedIn.
View original
content:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-301749164.html
SOURCE AbbVie